US Stock MarketDetailed Quotes

DYN Dyne Therapeutics

Watchlist
  • 23.990
  • -0.310-1.28%
Close Dec 20 16:00 ET
  • 23.990
  • 0.0000.00%
Post 20:01 ET
2.44BMarket Cap-6.70P/E (TTM)

Dyne Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dyne Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Dyne Therapeutics Earnings Reports

  • Dyne Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 12 13:07 ET

  • Dyne Therapeutics | 8-K: Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 12 09:27 ET

  • Dyne Therapeutics | 8-K: Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

    Aug 12 17:17 ET

  • Dyne Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 17:07 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Ermenegildo Zegna NV
    ZGN
    +6.16%
    DexCom
    DXCM
    +5.57%
    New Fortress Energy
    NFE
    +5.37%
    Workday
    WDAY
    +2.33%
    eBay
    EBAY
    +1.66%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 12, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data